IMU

4.00%

4.8¢ imugene limited

thanks T&P

First 133 Last

Share
Profile

Follow
plumvj

695 Posts.

126

13/08/24

10:58

Post #: 75181744
Share

Originally posted by Tenacity & Patience: ↑

Hey plumvj,
You defiantly woke this morning with a few IMU queries on your mind.

Firstly, I think it reasonable to state studies take time and stating they need more, as they've done. In relation to the takeup of new patients entering the new studies, around the 12 sites in Australia and USA there's no reason why this can't be known. I suspect Quarterly reports would reveal this.The last quarterly report was at the end of May, so I'd expect an update on the patient uptake at the end of August ( just two weeks away ).

There's a few things to consider. IMU might be selective of its patient's. FDA requirements stipulate patients must have failed at least two other SOC treatments. These people are extremely ill and looking for a last chance. Some have left the study in earlier rounds, no doubt in desperation to try alternative's or as many potential solutions as possible, and who could blame them. In leaving or trying additional solutions to ours, they were deemed no longer in our trial data. Similarly, some may have died as they were too severely weakened by cancer and at least two treatments, before the effects of our treatment had sufficient time to take effect. Or possibly the levels of dosages whilst testing the safety and or efficacy of our drugs, were not enough in making a difference sufficient to control their cancer. Time and higher dosages - which is what we've been waiting 10 months for now, should tell us!

I fully understand how sensitive data needs to be collected and verified, thus taking time. IMU might be waiting on being able to administer higher dosages', resulting from successes and data just coming to hand.

I guess that's another possibility of news to drop in the next 4 months. It's certainly all coming though- be patient !!

-GO IMU!

Not Financial Advice - Opinions Only - DYOR!

Expand

thanks T&P

IMU Price at posting: 5.2¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 1 more message in this thread...

First 133 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.8¢		Change -0.002(4.00%)		Mkt cap ! $356.9M

Open	High	Low	Value	Volume
5.0¢	5.0¢	4.7¢	$2.298M	47.86M

Buyers (Bids)

No.	Vol.	Price($)
5	1925982	4.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.9¢	3452098	12

View Market Depth

No.	Vol.	Price($)
5	1925982	0.048
33	4297134	0.047
47	3841303	0.046
53	6064000	0.045
11	2329545	0.044

Price($)	Vol.	No.
0.049	2620667	8
0.050	2639213	14
0.051	6431004	11
0.052	2071350	7
0.053	418882	5

Last trade - 16.10pm 27/09/2024 (20 minute delay)

IMU (ASX) Chart

thanks T&P

ACCC seeks Olam divestments before it can buy Namoi Cotton

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

thanks T&P

Top Stories

ACCC seeks Olam divestments before it can buy Namoi Cotton

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News